The hope is a partnership. Like what we thought was Novartis. But real!
It's a different disease and this time there is P3 data to look at whilst embarking on a new one and the FDA seems to be shining a torch on the path (somewhat).
MSB's 'hand' in negotiating the deal for this one is now heavily weighted towards their benefit.
The upside (maybe) is the world knows SI has a massive set of testicles so don't even bother if the money isn't right!! Or his unique conditions (whatever the hell they are - I have guessed previously).
Whispers in the wind will be at an all time high now I reckon. By the looks of the SP movements in advance of the announcements recently, the whispers started a few days ago.
Ann: FDAs OTAT Agrees to Primary Endpoint for Back Pain, page-129
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
-0.005(0.42%) |
Mkt cap ! $1.341B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.20 | $1.14 | $10.44M | 8.934M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 45750 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 1476 | 1 |
View Market Depth
| Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.18 |
Change
-0.005 ( 0.31 %) |
||||
| Open | High | Low | Volume | ||
| $1.18 | $1.20 | $1.14 | 1465927 | ||
| Last updated 15.59pm 24/05/2024 ? | |||||
| MSB (ASX) Chart |